Umbilical cord-matrix stem cells induce the functional restoration of vascular endothelial cells and enhance skin wound healing in diabetic mice via the polarized macrophages

Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored th...

Full description

Saved in:
Bibliographic Details
Published inStem cell research & therapy Vol. 11; no. 1; pp. 39 - 15
Main Authors Zhang, Shichang, Chen, Li, Zhang, Guoying, Zhang, Bo
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 28.01.2020
BioMed Central
BMC
Subjects
Amputation
Angiogenesis
Animals
Antibodies
Chemotaxis
Diabetes
Diabetes mellitus
Diabetes Mellitus, Experimental - genetics
Diabetes therapy
Endothelial cells
Endothelial Cells - metabolism
Endothelial growth factors
Endothelium
Experiments
Female
Fetal Blood - metabolism
Inflammation
Interleukin 6
Interleukins
Laboratory animals
Leukocyte migration
Lipopolysaccharides
Macrophage Activation - genetics
Macrophages
Mesenchyme
Mice
Microscopy
Mitogens
Necrosis
Phenotypes
Plastic surgery
Prostaglandin E2
Prostaglandins
Prostaglandins E
Skin
Skin - physiopathology
Stem cell transplantation
Stem cells
Stem Cells - metabolism
Streptozocin
Surgery
Tumor necrosis factor-α
Tumors
Ulcers
Umbilical cord
Umbilical cord-derived matrix stem cells
Vascular endothelial cells
Vascular endothelial growth factor
Wound care
Wound healing
Wound Healing - genetics
Canada
Japan
United States > US
Vascular endothelial cells
Wound healing
Macrophages
Umbilical cord-derived matrix stem cells
Diabetes mellitus
Online AccessGet full text

Cover

Abstract Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism. UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro. Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-α and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs. Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice.
AbstractList Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism. UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro. Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-[alpha] and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs. Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice.
Background Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism. Methods UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro. Results Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-[alpha] and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs. Conclusions Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice. Graphical Keywords: Umbilical cord-derived matrix stem cells, Wound healing, Macrophages, Vascular endothelial cells, Diabetes mellitus
Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism.BACKGROUNDChronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism.UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro.METHODSUCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro.Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-α and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs.RESULTSOur results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-α and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs.Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice.CONCLUSIONSOur findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice.
Background Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism. Methods UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro. Results Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-α and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs. Conclusions Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice.
Abstract Background Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism. Methods UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro. Results Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-α and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs. Conclusions Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice. Graphical Abstract
Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports the important role of mesenchymal stem cells in diabetic wound healing; however, the underlying mechanism remains unclear. Here, we explored the effects of umbilical cord-matrix stem cells (UCMSCs) on diabetic wound healing and the underlying mechanism. UCMSCs or conditioned medium (UCMSC-CM) were injected into the cutaneous wounds of streptozotocin-induced diabetic mice. The effects of this treatment on macrophages and diabetic vascular endothelial cells were investigated in vivo and in vitro. Our results reveal that UCMSCs or UCMSC-CM accelerated wound healing by enhancing angiogenesis. The number of host macrophages recruited to the wound tissue by local infusion of UCMSCs was greater than that recruited by fibroblast transplantation or control. The frequency of M2 macrophages was increased by UCMSC transplantation or UCMSC-CM injection, which promoted the expression of cytokines derived from M2 macrophages. Furthermore, when cocultured with UCMSCs or UCMSC-CM, lipopolysaccharide-induced macrophages acquired an anti-inflammatory M2 phenotype characterized by the increased secretion of the cytokines interleukin (IL)-10 and vascular endothelial growth factor and the suppressed production of tumor necrosis factor-α and IL-6. UCMSC-CM-activated macrophages significantly enhanced diabetic vascular endothelial cell functions, including angiogenesis, migration, and chemotaxis. Moreover, the action of UCMSC-CM on macrophages or vascular endothelial cells was abrogated by the administration of neutralizing antibodies against prostaglandin E2 (PGE2) or by the inhibition of PGE2 secretion from UCMSCs. Our findings demonstrate that UCMSCs can induce the functional restoration of vascular endothelial cells via the remodeling of macrophage phenotypes, which might contribute to the marked acceleration of wound healing in diabetic mice.
ArticleNumber 39
Audience Academic
Author Zhang, Guoying
Zhang, Shichang
Chen, Li
Zhang, Bo
Author_xml – sequence: 1
  givenname: Shichang
  orcidid: 0000-0002-6587-2518
  surname: Zhang
  fullname: Zhang, Shichang
– sequence: 2
  givenname: Li
  surname: Chen
  fullname: Chen, Li
– sequence: 3
  givenname: Guoying
  surname: Zhang
  fullname: Zhang, Guoying
– sequence: 4
  givenname: Bo
  surname: Zhang
  fullname: Zhang, Bo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31992364$$D View this record in MEDLINE/PubMed
BookMark eNp1k89u1DAQxiNUREvpA3BBkZAQHFLsOHGSC1JV8WelSkhAz9bEnuy6JPZiJ2XhoXhGJrstdCtIDslMft9nZzzzODlw3mGSPOXslPNavo5c5HWVsZxlvJQ82zxIjnhVVpkseX5w5_0wOYnxitElBGOyeJQcCt40uZDFUfLrcmhtbzX0qfbBZAOMwW7SOOKQauz7mFpnJo3puMK0m5werXcEB4yjDzBHqe_Sa4h66iGk6IwntLez4VYPzlB2BY5M4lfr0u9-otQKobduSfapsdDiaHU6WGKuLWwXW3vysz_RpAPo4NcrWGJ8kjzsoI94cvM8Ti7fvf1y_iG7-Ph-cX52kWmZl2NmWMNbwQWTHYoGJIeaU9gJLoumZk3XojZVIXLoNG8BmEYDeSdKaYqyKow4ThY7X-PhSq2DHSD8UB6s2iZ8WCoItOUelSmrykij67ZDUmIj0HDQDAFziiV5vdl5rad2QKPRjQH6PdP9L86u1NJfK9nUkouaDF7eGAT_baLCq8HGubjg0E9R5aKoc97wKif0-T30yk-BDmymyqqUJWvqv9QS6Aes6zytq2dTdSZ5LlkhqVeOk9N_UHQbpIOiZuws5fcEr_YExIy4GZcwxagWnz_tsy_usHMzjKvo-2luqLgPPrtbvT9lu21hAqodQE0SY8BOaTtuG5O2a3vFmZrnRe3mRdG8qHle1IaU_J7y1vz_mt8vuhlh
CitedBy_id crossref_primary_10_1186_s13287_022_02709_2
crossref_primary_10_1111_jcmm_15958
crossref_primary_10_1016_j_heliyon_2024_e37031
crossref_primary_10_3389_fimmu_2021_681710
crossref_primary_10_1111_jocd_15022
crossref_primary_10_3389_fbioe_2023_1158484
crossref_primary_10_1111_cpr_13586
crossref_primary_10_1111_jdi_14077
crossref_primary_10_1515_ntrev_2023_0165
crossref_primary_10_3390_ijms252212171
crossref_primary_10_1007_s12015_023_10540_2
crossref_primary_10_1016_j_pdpdt_2021_102480
crossref_primary_10_1007_s00403_022_02326_2
crossref_primary_10_1002_mco2_291
crossref_primary_10_3389_fcell_2021_643125
crossref_primary_10_1186_s13287_020_02131_6
crossref_primary_10_3389_fcell_2021_654210
crossref_primary_10_1016_j_curtheres_2025_100778
crossref_primary_10_1007_s11033_023_08782_x
crossref_primary_10_3389_fcell_2022_812262
crossref_primary_10_2174_1574888X15666200331135227
crossref_primary_10_1080_21645515_2022_2144667
crossref_primary_10_1177_0963689721993774
crossref_primary_10_1186_s13287_020_01755_y
crossref_primary_10_3389_fendo_2023_1099310
crossref_primary_10_5812_mca_106056
crossref_primary_10_1007_s00441_022_03697_8
crossref_primary_10_1038_s41536_024_00363_1
crossref_primary_10_1007_s00403_023_02739_7
crossref_primary_10_1186_s13287_022_02934_9
crossref_primary_10_34172_apb_2022_059
crossref_primary_10_1155_2022_2476493
crossref_primary_10_1186_s13287_020_01609_7
crossref_primary_10_3389_fcell_2022_1006295
crossref_primary_10_1007_s12015_025_10860_5
crossref_primary_10_3389_fbioe_2023_1264006
crossref_primary_10_1007_s12015_024_10806_3
crossref_primary_10_1016_j_tice_2025_102827
crossref_primary_10_3389_fbioe_2021_742858
crossref_primary_10_3389_fbioe_2022_965006
crossref_primary_10_1080_07853890_2024_2404186
crossref_primary_10_3390_bioengineering11060588
crossref_primary_10_1016_j_reth_2022_06_009
crossref_primary_10_5435_JAAOSGlobal_D_20_00054
crossref_primary_10_3390_pharmaceutics14102065
crossref_primary_10_1021_acsami_4c08174
crossref_primary_10_1155_2023_9324270
crossref_primary_10_1111_jcmm_16111
crossref_primary_10_1016_j_jdiacomp_2023_108671
crossref_primary_10_11648_j_bio_20241206_14
crossref_primary_10_1186_s12891_024_07799_y
crossref_primary_10_33380_2305_2066_2024_13_2_1727
crossref_primary_10_1007_s12015_020_09992_7
crossref_primary_10_1007_s12015_024_10835_y
Cites_doi 10.5966/sctm.2012-0031
10.1016/j.biomaterials.2012.09.022
10.1161/CIRCRESAHA.108.192138
10.1161/CIRCRESAHA.109.213140
10.3109/14653249.2012.706705
10.1016/j.jdermsci.2017.02.285
10.1002/jcb.24661
10.1186/s40001-019-0366-9
10.3727/096368914X682792
10.1126/science.1172687
10.1038/nbt.2978
10.1016/j.immuni.2016.02.015
10.1016/j.msec.2018.04.006
10.1152/physrev.00067.2017
10.2337/db12-1822
10.1172/JCI32169
10.1002/path.4133
10.7150/thno.29766
10.1038/jid.2010.155
10.1038/nprot.2007.54
10.7150/thno.18082
10.1038/nm.1905
10.1161/CIRCRESAHA.111.243147
10.1038/nri2395
10.1016/j.biopha.2018.08.013
10.1186/s13287-018-0854-9
10.1089/scd.2017.0025
10.1186/s13287-018-0921-2
10.1056/NEJMra1615439
10.1016/j.stem.2009.05.003
10.1016/j.molmed.2013.12.004
10.1002/stem.503
10.1016/j.stem.2018.01.014
10.1016/j.addr.2018.09.010
10.1097/MOT.0b013e328359a617
10.1046/j.1523-1747.2003.12484.x
10.1002/stem.1191
10.1089/ten.tea.2011.0516
10.1186/scrt468
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13287-020-1561-x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1757-6512
EndPage 15
ExternalDocumentID oai_doaj_org_article_d577d6dc8bfe4d3e93ed1ac0eae24d36
PMC6986138
A612604603
31992364
10_1186_s13287_020_1561_x
Genre Journal Article
GeographicLocations Canada
Japan
United States--US
GeographicLocations_xml – name: Canada
– name: Japan
– name: United States--US
GrantInformation_xml – fundername: ;
  grantid: 81671836; 81300507
GroupedDBID ---
0R~
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACIHN
ACJQM
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ISR
ITC
KQ8
LK8
M1P
M7P
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SBL
SOJ
SV3
TUS
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c625t-d091b31306fe39a61a81313f31649809fbecd7432afc1baa0ceda2f356d4574d3
IEDL.DBID 7X7
ISSN 1757-6512
IngestDate Wed Aug 27 01:24:04 EDT 2025
Thu Aug 21 18:29:42 EDT 2025
Fri Jul 11 16:23:36 EDT 2025
Fri Jul 25 12:09:50 EDT 2025
Tue Jun 17 21:30:20 EDT 2025
Tue Jun 10 20:18:05 EDT 2025
Fri Jun 27 04:53:47 EDT 2025
Thu May 22 21:09:53 EDT 2025
Thu Apr 03 07:06:35 EDT 2025
Tue Jul 01 00:43:23 EDT 2025
Thu Apr 24 22:53:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Vascular endothelial cells
Wound healing
Macrophages
Umbilical cord-derived matrix stem cells
Diabetes mellitus
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c625t-d091b31306fe39a61a81313f31649809fbecd7432afc1baa0ceda2f356d4574d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6587-2518
OpenAccessLink https://www.proquest.com/docview/2357565098?pq-origsite=%requestingapplication%
PMID 31992364
PQID 2357565098
PQPubID 2040189
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_d577d6dc8bfe4d3e93ed1ac0eae24d36
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6986138
proquest_miscellaneous_2348219172
proquest_journals_2357565098
gale_infotracmisc_A612604603
gale_infotracacademiconefile_A612604603
gale_incontextgauss_ISR_A612604603
gale_healthsolutions_A612604603
pubmed_primary_31992364
crossref_citationtrail_10_1186_s13287_020_1561_x
crossref_primary_10_1186_s13287_020_1561_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-28
PublicationDateYYYYMMDD 2020-01-28
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-28
  day: 28
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Stem cell research & therapy
PublicationTitleAlternate Stem Cell Res Ther
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References L Shin (1561_CR8) 2012; 1
Y Chen (1561_CR5) 2018; 9
M Gadelkarim (1561_CR23) 2018; 107
K Nemeth (1561_CR40) 2009; 15
H Brem (1561_CR21) 2007; 117
TA Wynn (1561_CR36) 2016; 44
Austin P. Veith (1561_CR2) 2019; 146
F Dong (1561_CR16) 2012; 17
LS Barcelos (1561_CR30) 2009; 104
M van de Vyver (1561_CR10) 2017; 26
Y Han (1561_CR33) 2019; 24
TF Mitts (1561_CR27) 2010; 130
RH Lee (1561_CR35) 2009; 5
TS Stappenbeck (1561_CR34) 2009; 324
H Shi (1561_CR12) 2017; 7
C Wang (1561_CR32) 2019; 9
SW Lane (1561_CR17) 2014; 32
R Shohara (1561_CR14) 2012; 14
H Kim (1561_CR7) 2015; 24
S Zhang (1561_CR26) 2012; 18
A Uccelli (1561_CR24) 2008; 8
B Baudin (1561_CR29) 2007; 2
K Futrega (1561_CR3) 2014; 20
C Loebel (1561_CR18) 2018; 22
A Uchiyama (1561_CR37) 2017; 86
QZ Zhang (1561_CR31) 2010; 28
CY Fong (1561_CR15) 2014; 115
M Rodrigues (1561_CR20) 2019; 99
N Bakhtyar (1561_CR13) 2018; 9
A O'Loughlin (1561_CR22) 2013; 62
C Hou (1561_CR4) 2013; 34
G Sun (1561_CR38) 2018; 89
RC Rennert (1561_CR9) 2014; 5
YP Jarajapu (1561_CR6) 2010; 106
RA Clark (1561_CR28) 2003; 121
JH Ylostalo (1561_CR39) 2012; 30
A Mantovani (1561_CR25) 2013; 229
DG Armstrong (1561_CR1) 2017; 376
LL Lu (1561_CR11) 2006; 91
AR Williams (1561_CR19) 2011; 109
References_xml – volume: 1
  start-page: 125
  year: 2012
  ident: 1561_CR8
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2012-0031
– volume: 34
  start-page: 112
  year: 2013
  ident: 1561_CR4
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2012.09.022
– volume: 104
  start-page: 1095
  year: 2009
  ident: 1561_CR30
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.108.192138
– volume: 106
  start-page: 854
  year: 2010
  ident: 1561_CR6
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.109.213140
– volume: 14
  start-page: 1171
  year: 2012
  ident: 1561_CR14
  publication-title: Cytotherapy.
  doi: 10.3109/14653249.2012.706705
– volume: 86
  start-page: 187
  year: 2017
  ident: 1561_CR37
  publication-title: J Dermatol Sci
  doi: 10.1016/j.jdermsci.2017.02.285
– volume: 115
  start-page: 290
  year: 2014
  ident: 1561_CR15
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.24661
– volume: 24
  start-page: 10
  year: 2019
  ident: 1561_CR33
  publication-title: Eur J Med Res
  doi: 10.1186/s40001-019-0366-9
– volume: 24
  start-page: 1571
  year: 2015
  ident: 1561_CR7
  publication-title: Cell Transplant
  doi: 10.3727/096368914X682792
– volume: 324
  start-page: 1666
  year: 2009
  ident: 1561_CR34
  publication-title: Science.
  doi: 10.1126/science.1172687
– volume: 32
  start-page: 795
  year: 2014
  ident: 1561_CR17
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2978
– volume: 44
  start-page: 450
  year: 2016
  ident: 1561_CR36
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2016.02.015
– volume: 89
  start-page: 194
  year: 2018
  ident: 1561_CR38
  publication-title: Mater Sci Eng C Mater Biol Appl
  doi: 10.1016/j.msec.2018.04.006
– volume: 99
  start-page: 665
  year: 2019
  ident: 1561_CR20
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00067.2017
– volume: 62
  start-page: 2588
  year: 2013
  ident: 1561_CR22
  publication-title: Diabetes.
  doi: 10.2337/db12-1822
– volume: 117
  start-page: 1219
  year: 2007
  ident: 1561_CR21
  publication-title: J Clin Invest
  doi: 10.1172/JCI32169
– volume: 229
  start-page: 176
  year: 2013
  ident: 1561_CR25
  publication-title: J Pathol
  doi: 10.1002/path.4133
– volume: 9
  start-page: 65
  year: 2019
  ident: 1561_CR32
  publication-title: Theranostics.
  doi: 10.7150/thno.29766
– volume: 130
  start-page: 2396
  year: 2010
  ident: 1561_CR27
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2010.155
– volume: 2
  start-page: 481
  year: 2007
  ident: 1561_CR29
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2007.54
– volume: 7
  start-page: 1674
  year: 2017
  ident: 1561_CR12
  publication-title: Theranostics.
  doi: 10.7150/thno.18082
– volume: 15
  start-page: 42
  year: 2009
  ident: 1561_CR40
  publication-title: Nat Med
  doi: 10.1038/nm.1905
– volume: 109
  start-page: 923
  year: 2011
  ident: 1561_CR19
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.111.243147
– volume: 8
  start-page: 726
  year: 2008
  ident: 1561_CR24
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2395
– volume: 107
  start-page: 625
  year: 2018
  ident: 1561_CR23
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.08.013
– volume: 9
  start-page: 99
  year: 2018
  ident: 1561_CR5
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-018-0854-9
– volume: 91
  start-page: 1017
  year: 2006
  ident: 1561_CR11
  publication-title: Haematologica.
– volume: 26
  start-page: 1042
  year: 2017
  ident: 1561_CR10
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2017.0025
– volume: 9
  start-page: 193
  year: 2018
  ident: 1561_CR13
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-018-0921-2
– volume: 376
  start-page: 2367
  year: 2017
  ident: 1561_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1615439
– volume: 5
  start-page: 54
  year: 2009
  ident: 1561_CR35
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2009.05.003
– volume: 20
  start-page: 137
  year: 2014
  ident: 1561_CR3
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2013.12.004
– volume: 28
  start-page: 1856
  year: 2010
  ident: 1561_CR31
  publication-title: Stem Cells
  doi: 10.1002/stem.503
– volume: 22
  start-page: 325
  year: 2018
  ident: 1561_CR18
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2018.01.014
– volume: 146
  start-page: 97
  year: 2019
  ident: 1561_CR2
  publication-title: Advanced Drug Delivery Reviews
  doi: 10.1016/j.addr.2018.09.010
– volume: 17
  start-page: 670
  year: 2012
  ident: 1561_CR16
  publication-title: Curr Opin Organ Transplant
  doi: 10.1097/MOT.0b013e328359a617
– volume: 121
  start-page: 695
  year: 2003
  ident: 1561_CR28
  publication-title: J Invest Dermatol.
  doi: 10.1046/j.1523-1747.2003.12484.x
– volume: 30
  start-page: 2283
  year: 2012
  ident: 1561_CR39
  publication-title: Stem Cells
  doi: 10.1002/stem.1191
– volume: 18
  start-page: 1352
  year: 2012
  ident: 1561_CR26
  publication-title: Tissue Eng Part A
  doi: 10.1089/ten.tea.2011.0516
– volume: 5
  start-page: 79
  year: 2014
  ident: 1561_CR9
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt468
SSID ssj0000330064
Score 2.4645088
Snippet Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence supports...
Background Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing evidence...
Abstract Background Chronic nonhealing wounds represent one of the most common complications of diabetes and require advanced treatment strategies. Increasing...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 39
SubjectTerms Amputation
Angiogenesis
Animals
Antibodies
Chemotaxis
Diabetes
Diabetes mellitus
Diabetes Mellitus, Experimental - genetics
Diabetes therapy
Endothelial cells
Endothelial Cells - metabolism
Endothelial growth factors
Endothelium
Experiments
Female
Fetal Blood - metabolism
Inflammation
Interleukin 6
Interleukins
Laboratory animals
Leukocyte migration
Lipopolysaccharides
Macrophage Activation - genetics
Macrophages
Mesenchyme
Mice
Microscopy
Mitogens
Necrosis
Phenotypes
Plastic surgery
Prostaglandin E2
Prostaglandins
Prostaglandins E
Skin
Skin - physiopathology
Stem cell transplantation
Stem cells
Stem Cells - metabolism
Streptozocin
Surgery
Tumor necrosis factor-α
Tumors
Ulcers
Umbilical cord
Umbilical cord-derived matrix stem cells
Vascular endothelial cells
Vascular endothelial growth factor
Wound care
Wound healing
Wound Healing - genetics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yIPgifls9NYogCOU2SZumj6d4nD74oC7cW0jz4Za77R7XXV39o_wbnUm6ZYugLz62mXS7M5P5SCe_IeRlaUxQ3PK8sE2dF543uWK-ylHcCBfFXaq2-ChP58WHs_Jsr9UX1oQleODEuCNXVpWTzqom-MIJXwvvmLEzbzyH6wi2DT5vL5mKNhjSdHC2w2dMpuRRD2kXrCfMliBlYfl24ogiXv-fVnnPLU1LJvd80MktcnMIHulxeunb5Jrv7pDrqZ3kj7vk13yJpa7AdYo5Zb5E-P0tRahmihv0PYUEHERJIeij6NDSPiC9it1loojoKtBdcSr1ncPzWRctPjDON52DuwvUFNqftx39jl2ZKEab4ALh8TTt5baWYpt7-q018ccuMYFuf3pHlwZ7hi3AivX3yPzk3Ze3p_nQjyG3kCWtcwd8bgQ4PRm8qI1kRjG4DAJSrhrkGkAfHEQk3ATLGmNm1jvDgyilK8oKhHWfHHSrzj8k1DSFVM4x1dSigIhM4YndJjDLpDFMVhmZ7YSj7QBWjj0zLnRMWpTUSZ4a5KlRnnqbkdfjlMuE1PE34jco8ZEQQbbjDVA9Paie_pfqZeQZ6otOJ1ZHU6GPIWqU-MFZZORFpECgjQ4reb6aTd_r958_TYheDURhBf_RmuFgBHAKsbkmlIcTSrAEdjq8U1w9WKJeI5xRiTCJKiPPx2GcidV1nV9tkKZQHBN3npEHSc9HzgisTxayyEg1WQET1k1HunYRccplrSBYVI_-B68fkxsc1-6M5VwdkoP11cY_gXBw3TyNK_83GndhJA
  priority: 102
  providerName: Directory of Open Access Journals
Title Umbilical cord-matrix stem cells induce the functional restoration of vascular endothelial cells and enhance skin wound healing in diabetic mice via the polarized macrophages
URI https://www.ncbi.nlm.nih.gov/pubmed/31992364
https://www.proquest.com/docview/2357565098
https://www.proquest.com/docview/2348219172
https://pubmed.ncbi.nlm.nih.gov/PMC6986138
https://doaj.org/article/d577d6dc8bfe4d3e93ed1ac0eae24d36
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIviG8CoxiEhIQUrc6H4zyhFW0aPEyoUGnixXJsZ41Yk9K0UPij-Bu5c9ywCGkvlRJfEtdn35fPvyPkdapUKSIdhYku8jCxUREKZrMQ2Y1wUZHpsi3O-Oks-XienvuAW-vTKncy0Qlq02iMkR8iLEuKcG_i3fJ7iFWjcHfVl9C4SfYRugxndXae9TGWMTjroHL9ZiYT_LAF5wtWFfpM4LiwcDtQRw61_3_ZfEU5DRMnr2iik7vkjjch6VHH83vkhq3vk1tdUclfD8if2QITXmHsKXqW4QJB-LcUAZsphulbCm44MJSC6UdRrXXRQLpyNWYco2hT0l2KKrW1wVNalxW-0D2vagN35zhfaPutqulPrM1E0eYERQivp11Et9IUi93TH5VyH1uiG139toYuFFYOm4Msax-S2cnxl_enoa_KEGrwldahAQujiEH18dLGueJMCQaXZQyOVw7cLWFWGLBLIlVqVig11taoqIxTbpI0S0z8iOzVTW2fEKqKhAtjmCjyOAG7TOC53aJkmnGlGM8CMt4xR2oPWY6VMy6lc10Elx0_JfBTIj_lNiBv-0eWHV7HdcQT5HhPiFDb7kazupB-5UqTZpnhRkPHLPTe5rE1TOmxVTaCax6QFzhfZHdutRcY8ghsR47bznFAXjkKhNuoMZ_nQm3aVn74PB0QvfFEZQP_USt_PAJGChG6BpQHA0qQB3rYvJu40sujVv5bPQF52Tfjk5hjV9tmgzSJiNB9jwLyuJvn_cjEmKUc8yQg2WAFDIZu2FJXc4dWznMBJqN4en23npHbEa7KMQsjcUD21quNfQ7m3roYuTU9IvuT47NP05ELmsDvdPL1L35tWlg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0CpFCC6IN4FCDQIhIUVNnMRxDgiVR7VLSw_QlfZmHNvpRnSTZbNLt3xUv5GZPJZGSL31mHjsOJ7xvDyeIeRVpFQmmGZuqNPEDS1LXeHb2EV0Y7ooZppoi0M-GIVfxtF4g5x3d2EwrLLjiTWjNqVGH_kOpmWJMN2beD_75WLVKDxd7UpoNGSxb89OwWSr3g0_AX5fM7b3-ejjwG2rCrgadP2Fa0BCpgGwbp7ZIFHcV8KHxywAwyGB2WXwVwbkKlOZ9lOlPG2NYlkQcRNGcWgCGPcauQ6C10NjLx7Ha5-OFwQo4tvDU1_wnQqMPdjFaKOBoeS7q574q6sE_C8LLgjDfqDmBcm3d4fcblVWutvQ2F2yYYt75EZTxPLsPjkfTTHAFnBN0ZJ1p5j0f0UxQTTFY4GKgtkPBERB1aQoRhvvI53XNW1qwqBlRruQWGoLg7fCTnIcsO6vCgNvJ0iftPqZF_QUa0FR1HFB8MLwtPEg55pOge_R37mqPzZDsz3_Yw2dKqxUNgHeWT0goyvB10OyWZSFfUyoSkMujPFFmgQh6IEC7wmnma99rpTPY4d4HXKkblOkY6WOE1mbSoLLBp8S8CkRn3LlkLfrLrMmP8hlwB8Q42tATO1dvyjnx7LlFNJEcWy40TAxC7O3SWCNr7RnlWXwzB2yjfQim3uyawYld0FX5XjMHTjkZQ2B6T0KjB86VsuqksPv33pAb1qgrIR_1Kq9jgErhRnBepBbPUjgP7rf3BGubPlfJf_tVoe8WDdjT4zpK2y5RJhQMHQXMIc8auh8vTIBRkUHPHRI3NsBvaXrtxT5pM6OzhMBKqp4cvm0tsnNwdHXA3kwPNx_Sm4x3KGe7zKxRTYX86V9BqrmIn1e729Kflw1Q_kLJIOTiw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Umbilical+cord-matrix+stem+cells+induce+the+functional+restoration+of+vascular+endothelial+cells+and+enhance+skin+wound+healing+in+diabetic+mice+via+the+polarized+macrophages&rft.jtitle=Stem+cell+research+%26+therapy&rft.au=Chen%2C+Li&rft.au=Zhang%2C+Bo&rft.au=Zhang%2C+Shichang&rft.au=Zhang%2C+Guoying&rft.date=2020-01-28&rft.pub=BioMed+Central+Ltd&rft.issn=1757-6512&rft.eissn=1757-6512&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1186%2Fs13287-020-1561-x&rft.externalDBID=n%2Fa&rft.externalDocID=A612604603
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-6512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-6512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-6512&client=summon